Generic Diovan is coming. The Wall Street Journal reports that generics drugmaker Ranbaxy has scored an FDA approval to manufacture an off-brand version of the blood pressure medication. The drug will ...

(Reuters) - Ranbaxy Laboratories Ltd (RANB.NS) has received approval from the U.S. Food and Drug Administration (FDA) to launch a cheaper copy of Novartis AG's blood pressure pill Diovan, bolstering ...

Ranbaxy Laboratories, which owns exclusive rights to generic Diovan for its first 180 days of marketing, hasn't won FDA approval for its copy. Copycat versions of Diovan HCT--a combo pill that ...

Novartis took its first big hit from new Diovan generics during last year's third quarter, when Ranbaxy Laboratories finally won approval for its exclusive generic of the blood pressure pill. And it ...

Credit: Getty Images. The approval was based on data from 3 clinical studies that assessed the antihypertensive effect of valsartan in 290 children 1 to less than 6 years of age. The Food and Drug ...

Diovan HCT is used for the treatment of high blood pressure (:HBP). According to IMS Health, Diovan HCT (80/12.5 mg, 160/12.5 mg, 160/25 mg, 320/12.5 mg and 320/25 mg tablets), generated US revenues ...

Although the patent on valsartan (Diovan, Novartis) expired last Friday, a generic version of the popular antihypertensive drug has yet to make it to market. By contrast, a generic version of Diovan ...

ZURICH (Reuters) - Novartis (NOVN.VX) plans to axe around 500 jobs in shutting a U.S. plant that makes its blood pressure pill Diovan, marking the second reorganization of its operations in as many ...

Problems surrounding the blood pressure-lowering drug Diovan have shed fresh light on opaque and sometimes questionable ties between medical researchers and pharmaceutical firms. More facts behind the ...

EAST HANOVER, N.J., Aug. 4 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved two single-pill combination medications, Diovan HCT(R) (valsartan and hydrochlorothiazide) and Exforge ...